676 Zhao, Zhou, and Li
a Nicolet 6700 FT-IR (Thermo Electron Corporation,
USA) spectrometer in KBr pellets. H NMR spectra
(KBr) ν: 3323, 3208, 2202, 1739, 1672, 1608,
1473, 1361, 1221, 1113, 1087, 976, 922, 868, 764,
578 cm−1. 1H NMR (DMSO-d6, 300 MHz) δ: 6.81
(d, J = 7.9 Hz, 1H, ArH), 7.38 (d, J = 7.9 Hz, 1H,
1
were recorded in DMSO-d6 on a Bruker Avance 300
(300 MHz; Swiss Bruker Corporation, Switzerland)
instrument with the TMS at δ0.00 ppm as an internal
standard. Chemicals used are of commercial grade,
without further purification.
ArH), 7.48–7.54 (m, 3H, ArH), 7.74 (s, 2H, NH ),
2
7.79 (d, J = 7.9 Hz, 1H, ArH), 7.92 (d, J = 7.5 Hz,
1H, ArH).
2-Amino-5-oxo-7-thioxo-spiro[(3ꢁH)-indol-3ꢁ,4,4
(H)-5,6,7,8-tetrahydropyrano(2,3-d)pyramidine]-(1ꢁ
H)-2ꢁ-one-3-carbonitrile (4p, C15H9N5O3S) mp 240–
242◦C (lit. [10] 238–242◦C); IR (KBr) ν: 3508, 3427,
3308, 3160, 2202, 1693, 1656, 1569, 1470, 1400,
Typical Procedure for Preparation of
Spirooxindole Derivatives
A mixture of isatin 1 (1.0 mmol), malononitrile 2
(1.0 mmol), and carbonyl compound 3 (1.0 mmol) in
H2O (5.0 mL) was stirred at 60◦C for 15–120 min. The
reaction was monitored by thin layer chromatogra-
phy (TLC). Upon completion, the reaction mixture
was allowed to cool to room temperature. Then, the
precipitated product was filtered and washed with
water and the crude product was purified by cooled
ethanol to afford the pure product 4.
1
1343, 1185, 1133, 919, 868, 768, 580 cm−1. H NMR
(DMSO-d6, 300 MHz) δ: 6.79 (d, J = 7.1 Hz, 1H,
ArH), 6.90 (t, J = 7.1 Hz, 1H, ArH), 7.16 (t, J = 8.1
Hz, 2H, ArH), 7.42 (s, 2H, NH ), 10.54 (s, 1H, NH),
2
12.51 (s, 1H, NH).
Ethyl
2ꢁ-Amino-3ꢁ-cyano-6ꢁ-methyl-2-oxospiro
[indoline-3,4ꢁ-pyran]-5ꢁ-carboxylate (8q, C17H15N3O4)
mp 259–260◦C (lit. [13] 258–260◦C); IR (KBr)
ν: 3484, 3160, 2188, 1713, 1620, 1472, 1380,
1288, 1212, 1072 cm−1. 1H NMR (DMSO-d6, 300
2-Amino-7,7-dimethyl-2ꢁ,5-dioxo-5,6,7,8-tetrahy-
drospiro[chromene-4,3ꢁ-indoline]-3-carbonitrile (4a,
C19H17N3O3) mp > 300◦C (lit. [13] > 300◦C); IR
(KBr) ν: 3377, 3312, 3144, 2192, 1723, 1683, 1655,
MHz) δ: 0.76 (t, J = 7.1 Hz, 3H, CH ), 2.30
3
(s, 3H, CH ), 3.34 (s, 2H, NH ), 3.73–3.77 (m, 2H,
3
2
1
1472, 1349, 1223, 1055 cm−1. H NMR (DMSO-d6,
CH ), 6.76 (d, J = 7.6 Hz, 1H, ArH), 6.92 (t, J = 7.2
2
300 MHz) δ: 0.98 (s, 3H, CH ), 1.04 (s, 3H, CH ),
Hz, 1H, ArH), 7.08 (d, J = 7.2 Hz, 1H, ArH), 7.20
(t, J = 7.6 Hz, 1H, ArH), 10.39 (s, 1H, NH).
3
3
2.10 (d, J = 16.0 Hz, 1H, CH ), 2.18 (d, J = 16.0 Hz,
2
1H, CH ), 2.48 (d, J = 18.0 Hz, 1H, CH ), 2.54
2
2
(d, J = 18.0 Hz, 1H, CH ), 6.78 (d, J = 7.6 Hz, 1H,
2
REFERENCES
ArH), 6.88 (t, J = 7.2 Hz, 1H, ArH), 6.95 (d, J =
7.2 Hz, 1H, ArH), 7.13 (t, J = 7.6 Hz, 1H, ArH), 7.23
[1] (a) Galliford, C. V.; Scheidt, K. A. Angew Chem Int
Ed Engl 2007, 46, 8748–8758; (b) Williams, R. M.;
Cox, R. J. Acc Chem Res 2003, 36, 127–139; (c) Ding,
K.; Lu, Y.; Nikolovska-Coleska, Z.; Wang, G.; Qiu, S.;
Shangary, S.; Gao, W.; Qin, D.; Stuckey, J.; Krajewski,
K.; Roller, P. P.; Wang, S. J Med Chem 2006, 49, 3432–
3435.
[2] Kornet, M. J.; Thio, A. P. J Med Chem 1976, 19, 892–
898.
[3] Cui, C. B.; Kakeya, H.; Osada, H. Tetrahedron 1996,
52, 12651–12666.
[4] Kang, T. H.; Matsumoto, K.; Murakami. Y.;
Takayama, H.; Kitajima, M.; Aimi, N.; Watanabe, H.
Eur J Pharmacol 2002, 444, 39–45.
[5] Shanthi, G.; Subbulakshmi, G.; Perumal, P. T. Tetra-
hedron 2007, 63, 2057–2063.
[6] Zhu, S. L.; Ji, S. J.; Zhang, Y. Tetrahedron 2007, 63,
9365–9372.
[7] Shemchuk, L.; Chernykh, V.; Red’kin, R. Russ J Org
Chem 2008, 44, 1789–1794.
[8] Gao, S.; Tsai, C. H.; Tseng, C.; Yao, C. F. Tetrahedron
2008, 64, 9143–9149.
[9] Li, Y.; Chen, H.; Shi, C.; Shi, D.; Ji, S. J Comb Chem
2010, 12, 231–237.
[10] Hari, G. S.; Lee, Y. R. Synthesis 2010, 453–464.
[11] (a) Elinson, M. N.; Ilovaisky, A. I.; Merkulova, V.
M.; Demchuk, D. V.; Belyakov, P. A.; Ogibin, Y. N.;
Nikishin, G. I. Electrochim Acta 2008, 53, 8346–
8350; (b) Elinson, M.; Dorofeev, A.; Miloserdov, F.;
Nikishin, G. Mol Divers 2009, 13, 47–52.
(s, 2H, NH ).
2
2-Amino-5ꢁ-methyl-2ꢁ,5-dioxo-1ꢁ,2ꢁ,5,6,7,8-hexahy-
drospiro[chromene-4,3ꢁ-indole]-3-carbonitrile
(4g,
C18H15N3O3) mp 288◦C (lit. [11] 287◦C); IR (KBr)
ν: 3362, 3145, 2195, 1658, 1603, 1351, 1213, 1075,
1009 cm−1. 1H NMR (DMSO-d6, 300 MHz) δ: 1.90 (t,
J = 6.0 Hz, 2H, CH ), 2.19–2.21 (m, 5H, CH , CH ),
2
3
2.64 (t, J = 5.9 Hz, 2H, CH ), 6.65 (d, J = 27.8 Hz,
2
1H, ArH), 6.80 (s, 1H, ArH), 6.92 (d, J = 7.8 Hz, 1H,
ArH), 7.19 (s, 2H, NH ).
2
6ꢁ-Amino-3ꢁ-methyl-2-oxo-1ꢁ-phenyl-1ꢁH-spiro[in-
doline-3,4ꢁ-pyrano[2,3-c]pyrazole]-5ꢁ-carbonitrile (4i,
C21H15N5O2) mp 238–240◦C (lit. [13] 236–237◦C);
IR (KBr) ν: 3461, 3296, 3178, 2196, 1701, 1655,
1595, 1470, 1392, 1331, 1221, 1127, 1070 cm−1. H
1
NMR (DMSO-d6, 300 MHz) δ: 1.53 (s, 3H, CH ),
3
6.94 (d, J = 7.3 Hz, 1H, ArH), 7.02 (t, J = 7.3 Hz,
1H, ArH), 7.17 (d, J = 7.1 Hz, 1H, ArH), 7.27 (t,
J = 7.3 Hz, 1H, ArH), 7.35 (d, J = 7.3 Hz, 1H, ArH),
7.50 (t, J = 7.0 Hz, 2H, ArH), 7.57 (s, 2H, NH ), 7.78
2
(d, J = 7.3 Hz, 2H, ArH), 10.74 (s, 1H, NH).
2ꢁ-Amino-5-bromo-2,5ꢁ-dioxo-5ꢁH-spiro[indoline-
3,4ꢁ-pyrano[3,2-c]chromene]-3ꢁ-carbonitrile
(4m,
C20H10N3O4) mp > 300◦C (lit. [13] > 300◦C); IR
Heteroatom Chemistry DOI 10.1002/hc